Showing 1 - 1 results of 1 for search 'E. Robenshtok', query time: 0.01s Refine Results
  1. 1
    Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

    Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit by L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: